SlideShare une entreprise Scribd logo
1  sur  11
Télécharger pour lire hors ligne
“ASSESSMENT OF QUALITY-OF-LIFE (QOL) IN
PATIENTS UNDERGOING CONVENTIONAL
VENTRAL HERNIOPLASTY’’
Candidate- Dr. Souparno Mandal
1st year post graduate trainee, Dept Of General Surgery
Guide- Prof .Dr Manju Banerjee, Department of General Surgery
AIMS AND OBJECTIVES
To evaluate improvement in post-operative quality of life of patients of ventral hernia who have undergone open
polypropylene mesh hernioplasty.
Specific objectives of my study are to
A. evaluate improvement in: -
1) Physical pain
2) Functional ability: - dressing, walking, climbing stairs, squatting etc.
3) Cosmesis
4) Psychological agony
B. To evaluate any Post operative complications if any
METHODOLOGY
1. Study design – Observational prospective study
2. Study timelines- June 2023- December 2024
3. Place of study- Department of General Surgery JIMSH, Buita, Budge-Budge, Kolkata 700137
4. Period of study- 18 months
5. Study population – All patients admitted for ventral hernioplasty during the study period with fulfilment of the study population criteria.
6. Sample size- By applying the statistical formula i.e., 1.96^2pq/l^2, the minimum number of sample size with 95% confidence interval and
marginal error 5% should be ~31. Where ‘p’ = 0.02 and ‘q = (1-p) =0.98 as Prevalence=2%. I would like to decrease the marginal error from
5% to 3.5% to make the study more significant. With 3.5% marginal error, my sample size should be ~ 62. R. Le Huu Nho et all conducted a
study on ventral and incisional hernia. As per that study prevalence is 2%.
7.Inclusion criteria
All elective patients having ventral hernias who will be undergoing open polypropylene mesh hernioplasty in Department of General
Surgery of the institute
1. Age 18years and above
2. ASA score up to III
3. Patients who give consent for prosthetic repair
4. Patients who will be available for follow up
8. Exclusion criteria:
1. Age less than 18 years
2. ASA score>III
3. Patients unwilling to undergo prosthetic repair
4. Patients who will not be available for follow-up
Data collection and interpretation-from the OPD and BHT of the patient
Data collection:
A. Name
B. Age
C. Sex
D. Occupation
E. Address
F. Religion
G. Date of admission
H. Chief complaints
I. History of present illness
J. History of past illness
K. Comorbidity, History of tuberculosis, thyroid disorder
L. PERSONAL HISTORY
1. Diet- Veg / non-veg
2. Urine- Normal / Polyuria
3. Sleep- Sound / Disturbed
4. Addiction to smoking or alcohol – Yes / No
5. Family History Of tuberculosis – Yes / No
6. Allergy history
7. Any skin conditions
M. Examination
• i. General Examination: -
1. Build - well / mod / poor
2. Decubitus –
3. BP –
4. PR –
5. Respiration –
6. Temperature – Normal / Raised
7. Pallor - Yes / No
8. Icterus –
9. Cyanosis –
10. Clubbing –
11. Oedema –
12. Lymph nodes –
13. Neck veins – Normal / Raised
14. Body weight
15. Height
16. BMI
• ii. Abdominal examination and examination of hernia site – number, gap in the scar, tone of abdominal muscles, position of rectus abdominis.
• iii. Systemic examination
• 1. Cardiovascular system
• 2. Respiratory system
• 3. Neurological system
• N. HerQLes” (Hernia related Quality of Life survey) form to be filled up on date of first attendance.
• 2. INVESTIGATION:
• a. Blood- Complete Blood count,
• Blood urea,
• serum creatinine,
• blood sugar assessment,
• blood coagulation profile,
• Lipid profile,
• Liver function test,
• Serology (HIV, Hepatitis B and Hepatitis C)
• b. Chest x-ray: -
• Postero-Antero view
• c. Electrocardiography,
• d. Ultrasonography of abdomen and anterior abdominal wall
• e. CT- as per requirement
• STUDY TOOLS: - Bed head ticket,outdoor ticket, Predesigned proforma, adapted from “HerQLes” (Hernia related Quality of Life
survey) will be used for data collection by doing serial interview with the patients. The HerQLes is a questionnaire which has 12 items.
By this tool we can assess functional improvement of abdominal wall after ventral hernia repair. Some modification is made with respect
to sociodemographic distribution of our patient population.
• STUDY TECHNIQUE: - At first, the purpose of this study will be explained in patient’s own language. Patients will be informed that
they can refuse to participate at any point and that will not affect in management. Based on HerQLes data will be collected preoperatively
and then every day till 7th post-operative day and then 1st and 4th month of follow up. Patient’s outdoor ticket, bed head ticket and
discharge certificates will be studied thoroughly while collecting data.
Hernia Related Quality Of
Life Survey (HerQLes) Tool
Score and Interpretation
9 – BEST OUTCOME
10-22- GOOD OUTCOME
23-35- MODERATELY BAD OUTCOME
36-45- POOR OUTCOME
LOWER THE SCORE BETTER THE PROGNOSIS,HIGHER THE SCORE POORER THE OUTCOME
• Consent Form
*PART 1 of 2
• INFORMATION FOR PARTICIPANTS OF THE STUDY
• PARTICIPANT INFORMATION SHEET
• Instructions - This is the patient information sheet. It should address the participant of this study. Depending upon the nature of the individual project, the details
provided to the participant may vary. A separate consent form for the patient/test group and control (drug/procedure or placebo) should be provided as
applicable. While formulating this sheet, the investigator must provide the following information as applicable in a simple language in English and Bengali which
can be understood by the participant
• Title of the project- Assessment of quality of life (QOL) in patients undergoing conventional Ventral hernioplasty.
• Name of the investigator/guide- Dr.Souparno Mandal/ Prof. Dr. Manju Banerjee, Head of department, Department of General Surgery.
• Purpose of this project/study- Assessment of quality of life (QOL) in patients undergoing conventional Ventral hernioplasty.
• Procedure/methods of the study- An observational prospective study.
• Expected duration of the subject participation- : June 2023 to December December 2024.
• The benefits to be expected from the research to the participant or to others and the post trial responsibilities of the investigator
• Any risks expected from the study to the participant - No
• Maintenance of confidentiality of records- Yes
• Provision of free treatment for research related injury- Yes
• Compensation of the participants not only for disability or death resulting from such injury but also for unforeseeable risks- Since it is an observational prospective
study any risk or study related injury involving the patient is not expected, hence compensation issue does not arise.
• Freedom to withdraw from the study at any time during the study period without the loss of benefits that the participant would otherwise be entitled to - Yes
• Possible current and future uses of the biological material and of the data to be generated from the research and if the material is likely to be used for secondary
purposes or would be shared with others- Yes
• Address and telephone number of the investigator and co-investigator/guide – Souparno Mandal, 9699879775 dr.souparnomandal@gmail.com
• Prof. Manju Banerjee, mob no- 833597779, manjubanerjee2022@gmail.com
• The patient information sheet must be duly signed by the investigator.
• CONSENT FORM
• PART 2 of 2- Participant consent form
• Protocol Study number:
• Patient identification number for this study:
• Title of the project: ASSESSMENT OF QUALITY-OF-LIFE (QOL) IN PATIENTS UNDERGOING CONVENTIONAL VENTRAL HERNIOPLASTY
• Name of Principal investigator: Souparno Mandal
• Tel. No(s) - 9699879775
• The contents of the information sheet dated that was provided have been read carefully by me / explained in detail to me, in a language that I comprehend, and I have fully understood the contents. I confirm that
I have had the opportunity to ask questions.
• The nature and purpose of the study and its potential risks / benefits and expected duration of the study, and other relevant details of the study have been explained to me in detail. I understand that my
participation is voluntary and that I am free to withdraw from the study at any time, without giving any reason, without my medical care or legal right being affected.
• I agree to take part in the above study
• Signatures / Left Thumb Impression)
• Date:
• Place:
• i understand that the information collected about me from my participation in this research and sections of any of my medical notes may be looked at by responsible individuals from JIMSH, Budge budge. I give
permission for these individuals to have access to my records.
•
• I agree to take part in the above study
• --------------------------------------------
• (Signatures / Left Thumb Impression)
Name of Participant: Son/Daughter/spouse of:
• Complete postal address:
• This is to certify that the above consent has been obtained in my presence.
• -------------------------------------------- ………………………………….
• Signatures of the Principal Investigator Signatures of the Witness
•
Date-
Place-
-
I, Mr. / Mrs. ___________________________ have been informed about all the aspects of the study, by the investigator verbally in a language
known to me. I have been given the opportunity to discuss all aspects of the study, to ask questions and hereby consent to participation in the
study.
I understand that my participation in this study is voluntary, and I am free to withdraw at any time, without having to give any reason and
without my rights and privileges being affected.
I understand that my data will be kept confidential, but the individuals appointed by principal investigator, ethics committee of the institution
where the study is being conducted and the regulatory authority will have access to the records both in respect of the current study and future
research that may be conducted in relation to it. Even if I withdraw, I agree to this access. However, I understand that my identity will not be
revealed, and confidentiality of the information will be maintained.
I agree to take part in this study voluntarily.
Signature of participant / Left thumb impression of participant:
Date:
CONSENT FORM

Contenu connexe

Similaire à prof.dr.manju maam ppt (3).pptx

Health assessment GNM & B.Sc.pptx
Health assessment GNM & B.Sc.pptxHealth assessment GNM & B.Sc.pptx
Health assessment GNM & B.Sc.pptxMandeepArya4
 
4 ethical principles for n ursing research
4 ethical principles for n ursing research4 ethical principles for n ursing research
4 ethical principles for n ursing researchAlels Mirabueno
 
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMU
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMUGuide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMU
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMUAhmad Ozair
 
1 senior training assessment-11th march 2022
1 senior training assessment-11th march 20221 senior training assessment-11th march 2022
1 senior training assessment-11th march 2022FinnianShardlow
 
Good Clinical Practice [Autosaved].pptx
Good Clinical Practice [Autosaved].pptxGood Clinical Practice [Autosaved].pptx
Good Clinical Practice [Autosaved].pptxAjeem Mohamed
 
Examination & diagnosis of edentulous patients
Examination & diagnosis of edentulous patients Examination & diagnosis of edentulous patients
Examination & diagnosis of edentulous patients Jehan Dordi
 
Health Assessment ON ABDOMEN (1) for midwifery students.pptx
Health Assessment ON ABDOMEN (1) for midwifery students.pptxHealth Assessment ON ABDOMEN (1) for midwifery students.pptx
Health Assessment ON ABDOMEN (1) for midwifery students.pptxEndex Tam
 
Screening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityScreening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityDrSumanB
 
Hospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHemanthiJetti
 
Informed Concent Form
Informed Concent FormInformed Concent Form
Informed Concent FormTosha Dave
 
8 senior training care-homes-11th february 2022
8 senior training care-homes-11th february 20228 senior training care-homes-11th february 2022
8 senior training care-homes-11th february 2022FinnianShardlow
 
Physical & neurological examination
Physical & neurological  examinationPhysical & neurological  examination
Physical & neurological examinationNeha Bhatt
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol developmentSACHIN C P
 
Jawahar Thomas
Jawahar ThomasJawahar Thomas
Jawahar ThomasVshaw123
 
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...naseemashraf2
 

Similaire à prof.dr.manju maam ppt (3).pptx (20)

Health assessment GNM & B.Sc.pptx
Health assessment GNM & B.Sc.pptxHealth assessment GNM & B.Sc.pptx
Health assessment GNM & B.Sc.pptx
 
Gcp guidelines
Gcp guidelinesGcp guidelines
Gcp guidelines
 
4 ethical principles for n ursing research
4 ethical principles for n ursing research4 ethical principles for n ursing research
4 ethical principles for n ursing research
 
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMU
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMUGuide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMU
Guide to Obtaining IEC/IRB (ethics committee/review board) approval in KGMU
 
1 senior training assessment-11th march 2022
1 senior training assessment-11th march 20221 senior training assessment-11th march 2022
1 senior training assessment-11th march 2022
 
Good Clinical Practice [Autosaved].pptx
Good Clinical Practice [Autosaved].pptxGood Clinical Practice [Autosaved].pptx
Good Clinical Practice [Autosaved].pptx
 
Examination & diagnosis of edentulous patients
Examination & diagnosis of edentulous patients Examination & diagnosis of edentulous patients
Examination & diagnosis of edentulous patients
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Health Assessment ON ABDOMEN (1) for midwifery students.pptx
Health Assessment ON ABDOMEN (1) for midwifery students.pptxHealth Assessment ON ABDOMEN (1) for midwifery students.pptx
Health Assessment ON ABDOMEN (1) for midwifery students.pptx
 
Understanding Clinical Trials
Understanding Clinical TrialsUnderstanding Clinical Trials
Understanding Clinical Trials
 
Screening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityScreening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificity
 
Kalyan CV
Kalyan CVKalyan CV
Kalyan CV
 
Hospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdf
 
Informed Concent Form
Informed Concent FormInformed Concent Form
Informed Concent Form
 
Experimental study design.pptx
Experimental study design.pptxExperimental study design.pptx
Experimental study design.pptx
 
8 senior training care-homes-11th february 2022
8 senior training care-homes-11th february 20228 senior training care-homes-11th february 2022
8 senior training care-homes-11th february 2022
 
Physical & neurological examination
Physical & neurological  examinationPhysical & neurological  examination
Physical & neurological examination
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
 
Jawahar Thomas
Jawahar ThomasJawahar Thomas
Jawahar Thomas
 
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
 

Plus de SouparnaMandal1

chemotherapy ppt lecture JIMSH.pptx
chemotherapy ppt lecture JIMSH.pptxchemotherapy ppt lecture JIMSH.pptx
chemotherapy ppt lecture JIMSH.pptxSouparnaMandal1
 
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptx
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptxEffectiveness of vacuum assisted closure versus Surgical Debridement.pptx
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptxSouparnaMandal1
 
SURGERY AUDIT JANUARY 23.pptx
SURGERY AUDIT JANUARY 23.pptxSURGERY AUDIT JANUARY 23.pptx
SURGERY AUDIT JANUARY 23.pptxSouparnaMandal1
 
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptx
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptxCASE PRESENTATION-IRREGULAR BREAST LUMP.pptx
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptxSouparnaMandal1
 

Plus de SouparnaMandal1 (7)

6571552380502.ppt
6571552380502.ppt6571552380502.ppt
6571552380502.ppt
 
chemotherapy ppt lecture JIMSH.pptx
chemotherapy ppt lecture JIMSH.pptxchemotherapy ppt lecture JIMSH.pptx
chemotherapy ppt lecture JIMSH.pptx
 
BLOOD transfusion.pptx
BLOOD  transfusion.pptxBLOOD  transfusion.pptx
BLOOD transfusion.pptx
 
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptx
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptxEffectiveness of vacuum assisted closure versus Surgical Debridement.pptx
Effectiveness of vacuum assisted closure versus Surgical Debridement.pptx
 
SURGERY AUDIT JANUARY 23.pptx
SURGERY AUDIT JANUARY 23.pptxSURGERY AUDIT JANUARY 23.pptx
SURGERY AUDIT JANUARY 23.pptx
 
NIKHIL THESIS.pptx
NIKHIL THESIS.pptxNIKHIL THESIS.pptx
NIKHIL THESIS.pptx
 
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptx
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptxCASE PRESENTATION-IRREGULAR BREAST LUMP.pptx
CASE PRESENTATION-IRREGULAR BREAST LUMP.pptx
 

Dernier

Metabolism of lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptx
Metabolism of  lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptxMetabolism of  lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptx
Metabolism of lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptxDr. Santhosh Kumar. N
 
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptx
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptxAUDIENCE THEORY - PARTICIPATORY - JENKINS.pptx
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptxiammrhaywood
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...Nguyen Thanh Tu Collection
 
Alamkara theory by Bhamaha Indian Poetics (1).pptx
Alamkara theory by Bhamaha Indian Poetics (1).pptxAlamkara theory by Bhamaha Indian Poetics (1).pptx
Alamkara theory by Bhamaha Indian Poetics (1).pptxDhatriParmar
 
POST ENCEPHALITIS case study Jitendra bhargav
POST ENCEPHALITIS case study  Jitendra bhargavPOST ENCEPHALITIS case study  Jitendra bhargav
POST ENCEPHALITIS case study Jitendra bhargavJitendra Bhargav
 
LEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudLEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudDr. Bruce A. Johnson
 
VIT336 – Recommender System - Unit 3.pdf
VIT336 – Recommender System - Unit 3.pdfVIT336 – Recommender System - Unit 3.pdf
VIT336 – Recommender System - Unit 3.pdfArthyR3
 
Quantitative research methodology and survey design
Quantitative research methodology and survey designQuantitative research methodology and survey design
Quantitative research methodology and survey designBalelaBoru
 
Material Remains as Source of Ancient Indian History & Culture.ppt
Material Remains as Source of Ancient Indian History & Culture.pptMaterial Remains as Source of Ancient Indian History & Culture.ppt
Material Remains as Source of Ancient Indian History & Culture.pptBanaras Hindu University
 
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdf
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdfPHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdf
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdfSumit Tiwari
 
Research Methodology and Tips on Better Research
Research Methodology and Tips on Better ResearchResearch Methodology and Tips on Better Research
Research Methodology and Tips on Better ResearchRushdi Shams
 
3.14.24 Gender Discrimination and Gender Inequity.pptx
3.14.24 Gender Discrimination and Gender Inequity.pptx3.14.24 Gender Discrimination and Gender Inequity.pptx
3.14.24 Gender Discrimination and Gender Inequity.pptxmary850239
 
Plant Tissue culture., Plasticity, Totipotency, pptx
Plant Tissue culture., Plasticity, Totipotency, pptxPlant Tissue culture., Plasticity, Totipotency, pptx
Plant Tissue culture., Plasticity, Totipotency, pptxHimansu10
 
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...gdgsurrey
 
The basics of sentences session 8pptx.pptx
The basics of sentences session 8pptx.pptxThe basics of sentences session 8pptx.pptx
The basics of sentences session 8pptx.pptxheathfieldcps1
 
3.12.24 The Social Construction of Gender.pptx
3.12.24 The Social Construction of Gender.pptx3.12.24 The Social Construction of Gender.pptx
3.12.24 The Social Construction of Gender.pptxmary850239
 
LEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudLEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudDr. Bruce A. Johnson
 
Riti theory by Vamana Indian poetics.pptx
Riti theory by Vamana Indian poetics.pptxRiti theory by Vamana Indian poetics.pptx
Riti theory by Vamana Indian poetics.pptxDhatriParmar
 
ICS2208 Lecture4 Intelligent Interface Agents.pdf
ICS2208 Lecture4 Intelligent Interface Agents.pdfICS2208 Lecture4 Intelligent Interface Agents.pdf
ICS2208 Lecture4 Intelligent Interface Agents.pdfVanessa Camilleri
 

Dernier (20)

Metabolism of lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptx
Metabolism of  lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptxMetabolism of  lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptx
Metabolism of lipoproteins & its disorders(Chylomicron & VLDL & LDL).pptx
 
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptx
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptxAUDIENCE THEORY - PARTICIPATORY - JENKINS.pptx
AUDIENCE THEORY - PARTICIPATORY - JENKINS.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
 
Alamkara theory by Bhamaha Indian Poetics (1).pptx
Alamkara theory by Bhamaha Indian Poetics (1).pptxAlamkara theory by Bhamaha Indian Poetics (1).pptx
Alamkara theory by Bhamaha Indian Poetics (1).pptx
 
POST ENCEPHALITIS case study Jitendra bhargav
POST ENCEPHALITIS case study  Jitendra bhargavPOST ENCEPHALITIS case study  Jitendra bhargav
POST ENCEPHALITIS case study Jitendra bhargav
 
LEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudLEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced Stud
 
VIT336 – Recommender System - Unit 3.pdf
VIT336 – Recommender System - Unit 3.pdfVIT336 – Recommender System - Unit 3.pdf
VIT336 – Recommender System - Unit 3.pdf
 
Quantitative research methodology and survey design
Quantitative research methodology and survey designQuantitative research methodology and survey design
Quantitative research methodology and survey design
 
Material Remains as Source of Ancient Indian History & Culture.ppt
Material Remains as Source of Ancient Indian History & Culture.pptMaterial Remains as Source of Ancient Indian History & Culture.ppt
Material Remains as Source of Ancient Indian History & Culture.ppt
 
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdf
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdfPHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdf
PHARMACOGNOSY CHAPTER NO 5 CARMINATIVES AND G.pdf
 
Research Methodology and Tips on Better Research
Research Methodology and Tips on Better ResearchResearch Methodology and Tips on Better Research
Research Methodology and Tips on Better Research
 
3.14.24 Gender Discrimination and Gender Inequity.pptx
3.14.24 Gender Discrimination and Gender Inequity.pptx3.14.24 Gender Discrimination and Gender Inequity.pptx
3.14.24 Gender Discrimination and Gender Inequity.pptx
 
Plant Tissue culture., Plasticity, Totipotency, pptx
Plant Tissue culture., Plasticity, Totipotency, pptxPlant Tissue culture., Plasticity, Totipotency, pptx
Plant Tissue culture., Plasticity, Totipotency, pptx
 
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...
Certification Study Group - Professional ML Engineer Session 3 (Machine Learn...
 
The basics of sentences session 8pptx.pptx
The basics of sentences session 8pptx.pptxThe basics of sentences session 8pptx.pptx
The basics of sentences session 8pptx.pptx
 
3.12.24 The Social Construction of Gender.pptx
3.12.24 The Social Construction of Gender.pptx3.12.24 The Social Construction of Gender.pptx
3.12.24 The Social Construction of Gender.pptx
 
LEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced StudLEAD6001 - Introduction to Advanced Stud
LEAD6001 - Introduction to Advanced Stud
 
Riti theory by Vamana Indian poetics.pptx
Riti theory by Vamana Indian poetics.pptxRiti theory by Vamana Indian poetics.pptx
Riti theory by Vamana Indian poetics.pptx
 
ICS2208 Lecture4 Intelligent Interface Agents.pdf
ICS2208 Lecture4 Intelligent Interface Agents.pdfICS2208 Lecture4 Intelligent Interface Agents.pdf
ICS2208 Lecture4 Intelligent Interface Agents.pdf
 
Least Significance Difference:Biostatics and Research Methodology
Least Significance Difference:Biostatics and Research MethodologyLeast Significance Difference:Biostatics and Research Methodology
Least Significance Difference:Biostatics and Research Methodology
 

prof.dr.manju maam ppt (3).pptx

  • 1. “ASSESSMENT OF QUALITY-OF-LIFE (QOL) IN PATIENTS UNDERGOING CONVENTIONAL VENTRAL HERNIOPLASTY’’ Candidate- Dr. Souparno Mandal 1st year post graduate trainee, Dept Of General Surgery Guide- Prof .Dr Manju Banerjee, Department of General Surgery
  • 2. AIMS AND OBJECTIVES To evaluate improvement in post-operative quality of life of patients of ventral hernia who have undergone open polypropylene mesh hernioplasty. Specific objectives of my study are to A. evaluate improvement in: - 1) Physical pain 2) Functional ability: - dressing, walking, climbing stairs, squatting etc. 3) Cosmesis 4) Psychological agony B. To evaluate any Post operative complications if any
  • 3. METHODOLOGY 1. Study design – Observational prospective study 2. Study timelines- June 2023- December 2024 3. Place of study- Department of General Surgery JIMSH, Buita, Budge-Budge, Kolkata 700137 4. Period of study- 18 months 5. Study population – All patients admitted for ventral hernioplasty during the study period with fulfilment of the study population criteria. 6. Sample size- By applying the statistical formula i.e., 1.96^2pq/l^2, the minimum number of sample size with 95% confidence interval and marginal error 5% should be ~31. Where ‘p’ = 0.02 and ‘q = (1-p) =0.98 as Prevalence=2%. I would like to decrease the marginal error from 5% to 3.5% to make the study more significant. With 3.5% marginal error, my sample size should be ~ 62. R. Le Huu Nho et all conducted a study on ventral and incisional hernia. As per that study prevalence is 2%.
  • 4. 7.Inclusion criteria All elective patients having ventral hernias who will be undergoing open polypropylene mesh hernioplasty in Department of General Surgery of the institute 1. Age 18years and above 2. ASA score up to III 3. Patients who give consent for prosthetic repair 4. Patients who will be available for follow up 8. Exclusion criteria: 1. Age less than 18 years 2. ASA score>III 3. Patients unwilling to undergo prosthetic repair 4. Patients who will not be available for follow-up Data collection and interpretation-from the OPD and BHT of the patient Data collection: A. Name B. Age C. Sex D. Occupation E. Address F. Religion G. Date of admission H. Chief complaints I. History of present illness J. History of past illness K. Comorbidity, History of tuberculosis, thyroid disorder
  • 5. L. PERSONAL HISTORY 1. Diet- Veg / non-veg 2. Urine- Normal / Polyuria 3. Sleep- Sound / Disturbed 4. Addiction to smoking or alcohol – Yes / No 5. Family History Of tuberculosis – Yes / No 6. Allergy history 7. Any skin conditions M. Examination • i. General Examination: - 1. Build - well / mod / poor 2. Decubitus – 3. BP – 4. PR – 5. Respiration – 6. Temperature – Normal / Raised 7. Pallor - Yes / No 8. Icterus – 9. Cyanosis – 10. Clubbing – 11. Oedema – 12. Lymph nodes – 13. Neck veins – Normal / Raised 14. Body weight 15. Height 16. BMI
  • 6. • ii. Abdominal examination and examination of hernia site – number, gap in the scar, tone of abdominal muscles, position of rectus abdominis. • iii. Systemic examination • 1. Cardiovascular system • 2. Respiratory system • 3. Neurological system • N. HerQLes” (Hernia related Quality of Life survey) form to be filled up on date of first attendance. • 2. INVESTIGATION: • a. Blood- Complete Blood count, • Blood urea, • serum creatinine, • blood sugar assessment, • blood coagulation profile, • Lipid profile, • Liver function test, • Serology (HIV, Hepatitis B and Hepatitis C) • b. Chest x-ray: - • Postero-Antero view • c. Electrocardiography, • d. Ultrasonography of abdomen and anterior abdominal wall • e. CT- as per requirement
  • 7. • STUDY TOOLS: - Bed head ticket,outdoor ticket, Predesigned proforma, adapted from “HerQLes” (Hernia related Quality of Life survey) will be used for data collection by doing serial interview with the patients. The HerQLes is a questionnaire which has 12 items. By this tool we can assess functional improvement of abdominal wall after ventral hernia repair. Some modification is made with respect to sociodemographic distribution of our patient population. • STUDY TECHNIQUE: - At first, the purpose of this study will be explained in patient’s own language. Patients will be informed that they can refuse to participate at any point and that will not affect in management. Based on HerQLes data will be collected preoperatively and then every day till 7th post-operative day and then 1st and 4th month of follow up. Patient’s outdoor ticket, bed head ticket and discharge certificates will be studied thoroughly while collecting data.
  • 8. Hernia Related Quality Of Life Survey (HerQLes) Tool Score and Interpretation 9 – BEST OUTCOME 10-22- GOOD OUTCOME 23-35- MODERATELY BAD OUTCOME 36-45- POOR OUTCOME LOWER THE SCORE BETTER THE PROGNOSIS,HIGHER THE SCORE POORER THE OUTCOME
  • 9. • Consent Form *PART 1 of 2 • INFORMATION FOR PARTICIPANTS OF THE STUDY • PARTICIPANT INFORMATION SHEET • Instructions - This is the patient information sheet. It should address the participant of this study. Depending upon the nature of the individual project, the details provided to the participant may vary. A separate consent form for the patient/test group and control (drug/procedure or placebo) should be provided as applicable. While formulating this sheet, the investigator must provide the following information as applicable in a simple language in English and Bengali which can be understood by the participant • Title of the project- Assessment of quality of life (QOL) in patients undergoing conventional Ventral hernioplasty. • Name of the investigator/guide- Dr.Souparno Mandal/ Prof. Dr. Manju Banerjee, Head of department, Department of General Surgery. • Purpose of this project/study- Assessment of quality of life (QOL) in patients undergoing conventional Ventral hernioplasty. • Procedure/methods of the study- An observational prospective study. • Expected duration of the subject participation- : June 2023 to December December 2024. • The benefits to be expected from the research to the participant or to others and the post trial responsibilities of the investigator • Any risks expected from the study to the participant - No • Maintenance of confidentiality of records- Yes • Provision of free treatment for research related injury- Yes • Compensation of the participants not only for disability or death resulting from such injury but also for unforeseeable risks- Since it is an observational prospective study any risk or study related injury involving the patient is not expected, hence compensation issue does not arise. • Freedom to withdraw from the study at any time during the study period without the loss of benefits that the participant would otherwise be entitled to - Yes • Possible current and future uses of the biological material and of the data to be generated from the research and if the material is likely to be used for secondary purposes or would be shared with others- Yes • Address and telephone number of the investigator and co-investigator/guide – Souparno Mandal, 9699879775 dr.souparnomandal@gmail.com • Prof. Manju Banerjee, mob no- 833597779, manjubanerjee2022@gmail.com • The patient information sheet must be duly signed by the investigator.
  • 10. • CONSENT FORM • PART 2 of 2- Participant consent form • Protocol Study number: • Patient identification number for this study: • Title of the project: ASSESSMENT OF QUALITY-OF-LIFE (QOL) IN PATIENTS UNDERGOING CONVENTIONAL VENTRAL HERNIOPLASTY • Name of Principal investigator: Souparno Mandal • Tel. No(s) - 9699879775 • The contents of the information sheet dated that was provided have been read carefully by me / explained in detail to me, in a language that I comprehend, and I have fully understood the contents. I confirm that I have had the opportunity to ask questions. • The nature and purpose of the study and its potential risks / benefits and expected duration of the study, and other relevant details of the study have been explained to me in detail. I understand that my participation is voluntary and that I am free to withdraw from the study at any time, without giving any reason, without my medical care or legal right being affected. • I agree to take part in the above study • Signatures / Left Thumb Impression) • Date: • Place: • i understand that the information collected about me from my participation in this research and sections of any of my medical notes may be looked at by responsible individuals from JIMSH, Budge budge. I give permission for these individuals to have access to my records. • • I agree to take part in the above study • -------------------------------------------- • (Signatures / Left Thumb Impression) Name of Participant: Son/Daughter/spouse of: • Complete postal address: • This is to certify that the above consent has been obtained in my presence. • -------------------------------------------- …………………………………. • Signatures of the Principal Investigator Signatures of the Witness • Date- Place- -
  • 11. I, Mr. / Mrs. ___________________________ have been informed about all the aspects of the study, by the investigator verbally in a language known to me. I have been given the opportunity to discuss all aspects of the study, to ask questions and hereby consent to participation in the study. I understand that my participation in this study is voluntary, and I am free to withdraw at any time, without having to give any reason and without my rights and privileges being affected. I understand that my data will be kept confidential, but the individuals appointed by principal investigator, ethics committee of the institution where the study is being conducted and the regulatory authority will have access to the records both in respect of the current study and future research that may be conducted in relation to it. Even if I withdraw, I agree to this access. However, I understand that my identity will not be revealed, and confidentiality of the information will be maintained. I agree to take part in this study voluntarily. Signature of participant / Left thumb impression of participant: Date: CONSENT FORM